1. |
刘晓玲, 孙心铨. 重视糖尿病视网膜病变以及眼底病激光光凝的规范化治疗[J]. 中华眼底病杂志, 2010, 26(2): 101-104. DOI: 10.3760/cma.j.issn.1005-1015.2010.02.01.Liu XL, Sun XQ. Standardization of laser treatment for diabetic retinopathy and other ocular fundus diseases[J]. Chin J Ocul Fundus Dis, 2010, 26(2): 101-104. DOI: 10.3760/cma.j.issn.1005-1015.2010.02.01.
|
2. |
Kim YJ, Jeong CB, Hwang JM, et al. New parametric imaging method with fluorescein angiograms for detecting areas of capillary nonperfusion[J]. Health Inform Res, 2014, 20(3): 191-198. DOI: 10.4258/hir.2014.20.3.191.
|
3. |
Hayreh SS, Zimmerman MB. Ocular neovascularization associated with central and hemicentral retinal vein occlusion[J]. Retina, 2012, 32(8): 1553-1565. DOI: 10.1097/IAE.0b013e318246912c.
|
4. |
Pieramici DJ, Avery RL. Ranibizumab: treatment in patients with neovascular age-related macular degeneration[J]. Expert Opin Biol Ther, 2006, 6(11): 1237-1245.
|
5. |
毛剑波, 褚梦琪, 陈亦棋, 等. 玻璃体腔注射康柏西普治疗视网膜静脉阻塞黄斑水肿短期疗效观察[J]. 中华眼底病杂志, 2016, 32(4): 372-376. DOI: 10.3760/cma.j.issn.1005-1015.2016.04.007.Mao JB, Chu MQ, Chen YQ, et al. The efficacy of intravitreal conbercept for macular edema secondary to retinal vein occlusion[J]. Chin J Ocul Fundus Dis, 2016, 32(4): 372-376. DOI: 10.3760/cma.j.issn.1005-1015.2016.04.007.
|
6. |
Rouvas A, Petrou P, Ntourski A, et al. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edma: nine-month result of a prospective study[J]. Retina, 2010, 30(6): 893-902.
|
7. |
Azad R, Vivek K, Sharma Y, et al. Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion[J]. Indian J Ophthalmol, 2012, 60(4): 263-266. DOI: 4103/0301-4738.98701.
|
8. |
郑红梅, 邢怡桥, 陈长征, 等. 玻璃体腔注射抗血管内皮生长因子单克隆抗体ranibizumab联合格栅样激光光凝治疗视网膜分支静脉阻塞合并黄斑水肿疗效观察[J]. 中华眼底病杂志, 2012, 28(5): 472-476. DOI: 10.3760/cma.j.issn.1005-1015.2012.05.010.Zheng HM, Xing YQ, Chen CZ, et al. Combined intravitreal ranibizumab and grid laser photocoagulation for branch retinal vein occlusion with macular edema[J]. Chin J Ocul Fundus Dis, 2012, 28(5): 472-476. DOI: 10.3760/cma.j.issn.1005-1015.2012.05.010.
|
9. |
解正高, 陈放, 朱俊, 等. BRVO合并黄斑水肿治疗中ranibizumab与黄斑格栅样光凝的联合应用[J]. 中华实验眼科杂志, 2015, 33 (6): 511-512. DOI: 10.3760/cma.j.issn.2095-0160.2015.06.006.Xie ZG, Chen F, Zhu J, et al. Combined application of BRVO combined with macular edema in treatment of ranibizumab and macular grille[J]. Chin J Exp Ophthalmol, 2015, 33(6): 511-512. DOI: 10.3760/cma.j.issn.2095-0160.2015.06.006.
|
10. |
宋爽, 喻晓兵, 戴虹. 玻璃体腔注射雷珠单抗联合曲安奈德或激光光凝治疗视网膜分支静脉阻塞继发黄斑水肿疗效观察[J]. 中华眼底病杂志, 2015, 31(1): 18-21. DOI: 10.3760/cma.j.issn.1005-1015.2015.01.006.Song S, Yu XB, Dai H. The efficacy of intravitreal ranibizumab and (or) triamcinolone combined with laser photocoagulation for macular edema secondary to branch retinal vein occlusion[J]. Chin J Ocul Fundus Dis, 2015, 31(1): 18-21. DOI: 10.3760/cma.j.issn.1005-1015.2015.01.006.
|
11. |
McIntosh RL, Mohamed Q, Saw SM, et al. Interventions for branch retinal vein occlusion: an evidence- based systematic review [J]. Ophthalmology, 2007, 114(5): 835-854. DOI: 10.1016/j.ophtha.2001.01.010.
|
12. |
Ohashi H, Oh H, Nishiwaki H, et al. Delayed absorption of macular edema accompanying serous retinal detachment after grid laser treatment in patients with branch retinal veinocclusion[J]. Ophthalmology, 2004, 111(11): 2050-2056. DOI: 10.1016/ophtha.2004.04.031.
|
13. |
Fan C, Wang Y, Ji Q, et al. Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion[J]. Curr Eye Res, 2014, 39(9): 938-943. DOI: 10.3109/02713683.2014.885533.
|
14. |
Maturi RK, Chen V, Raghinaru D, et al. A 6-month, subjectmasked, randomized controlled study to assess efficacy of dexamethasone as an adjunct to bevacizumab compared with bevacizumab alone in the treatment of patients with macular edema due to central or branch retinal vein occlusion [J]. Clin Ophthalmol, 2014, 8: 1057-1064. DOI: 10.2147/OPTH.S60159.
|